2007
DOI: 10.3324/haematol.10658
|View full text |Cite
|
Sign up to set email alerts
|

Elucidating the spectrum of  -thalassemia mutations in Iran

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
22
1
1

Year Published

2009
2009
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 46 publications
(28 citation statements)
references
References 8 publications
4
22
1
1
Order By: Relevance
“…In Guvenc et al's study, −(α) 20.5 mutation was the fourth most commonly seen mutation in 225 individuals carrying α-thalassemia allele or alleles [8]. It has also been reported rarely in the south Asia, Middle East and Arab countries [19][20][21][22][23][24].…”
Section: Resultsmentioning
confidence: 90%
See 1 more Smart Citation
“…In Guvenc et al's study, −(α) 20.5 mutation was the fourth most commonly seen mutation in 225 individuals carrying α-thalassemia allele or alleles [8]. It has also been reported rarely in the south Asia, Middle East and Arab countries [19][20][21][22][23][24].…”
Section: Resultsmentioning
confidence: 90%
“…--MED mutation seems to be specific to Mediterranean areas. It has been reported among the first three or four most frequent mutations in Mediterranean and Middle Eastern populations whereas it has not to been seen in Far Eastern populations [7,16,17,19,20,24,26].…”
Section: Resultsmentioning
confidence: 93%
“…[13][14][15] The commonest type of α-thalassemia seen in Iran is -α 3.7 deletion. At our hospital, the overall frequencies of α-thalassemia and β-thalassemia among microcytic, hypochromic anemia patients are 57% and 25.8%, respectively Hadavi et al [16] have reported the prevalence of -α 3.7 deletion to be 30.2% in the population of Iran (87 million). Our data showed the prevalence of -α 3.7 deletion to be 20% in the population of southwest (Khuzestan) region of Iran (4.3 million).…”
Section: Discussionmentioning
confidence: 99%
“…Hadavi et al [16] have reported -α 4.2 deletion in Iranian subjects, with a prevalence of 3.5%. Najmabadi et al [17,18] have reported the prevalence of IVS-II-I (G > A) beta-thalassemia mutation to be 34% in the population of Iran.…”
Section: Discussionmentioning
confidence: 99%
“…Fetus DNA was extracted from 3 ml amniotic fluid by using NucleoSpin Isolation Kit. Detection of known β-globin gene mutations was done using a commercialized reverse dot blot platform cd 142 (TAA>TCA) (Hb Koya Dora), α2 poly A-1 (AATAAA-AATAAG) and α2 poly A-2 (AATAAA-AATGAA) (Hadavi et al, 2007). Maternal contamination was eliminated using ChromoQuant version 2 kit (CyberGene AB, Sweden).…”
Section: Methodsmentioning
confidence: 99%